Document Detail


Cardiovascular risk factors and immunosuppressive regimen after liver transplantation.
MedLine Citation:
PMID:  20832547     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Cardiovascular and metabolic diseases represent important long-term complications after liver transplantation (LT), impairing long-term and disease-free survivals. A few mechanisms underlie the development of those complications, but the role of immunosuppressive drugs is major. Although several patients develop temporary metabolic diseases, which normalize after a short postoperative period and do not need long-term drug therapy, the incidences of de novo long-lasting arterial hypertension, hyperlipidemia, and diabetes mellitus are high during the first year after LT. The aim of this retrospective study was to evaluate new-onset arterial hypertension, hyperlipidemia, or diabetes among 100 LT patients at a single institution. We used chi-square statistical analysis to compare incidences during tacrolimus versus cyclosporine therapy. Hypertension did not seem to be more strongly related to tacrolimus than to cyclosporine, nor did diabetes, whereas there was a difference for the development of hyperlipidemia.
Authors:
A Rossetto; D Bitetto; V Bresadola; D Lorenzin; U Baccarani; D De Anna; F Bresadola; G L Adani
Related Documents :
15002927 - Inadequate control of blood pressure in nigerians with diabetes.
8591707 - Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats...
17605507 - Case study: the link between hypertension and diabetes.
9649957 - Hypertension and macrovascular disease--the killing fields of niddm.
20210567 - Insulin pump therapy in moslem patients with type 1 diabetes during ramadan fasting: an...
7716547 - Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin se...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  42     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2576-8     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Surgery and Transplantation, University Hospital, Udine, Italy. rossettoannaar@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Timing of conversion to mammalian target of rapamycin inhibitors is crucial in liver transplant reci...
Next Document:  Sirolimus in liver transplant recipients: a large single-center experience.